Literature DB >> 2783344

Raynaud syndrome in childhood.

C M Duffy1, R M Laxer, P Lee, C Ramsay, M Fritzler, E D Silverman.   

Abstract

Twenty-seven patients with Raynaud syndrome (mean age at onset 11.7 years) were studied to determine the prevalence of primary Raynaud syndrome and to assess the predictive role of antinuclear antibody, nail-fold capillary microscopy, and photoelectric plethysmography in this population. Fourteen patients (52%) had a connective tissue disease, four (15%) had a probable connective tissue disease, and nine (33%) had primary Raynaud syndrome. In all patients with either a connective tissue disease or a probable connective tissue disease, there was a positive reaction to antinuclear antibody, in contrast to patients with primary Raynaud syndrome, in whom antinuclear antibody was not detected. Nail-fold capillary microscopy scores differed significantly between patients with either a connective tissue disease or a probable connective tissue disease and those with primary Raynaud syndrome for both enlarged loop score (p less than 0.025 and less than 0.05, respectively) and avascular score (p less than 0.005 and less than 0.01, respectively). Photoelectric plethysmography scores were reduced in all groups but did not differ significantly between groups. Our findings suggest that in children with Raynaud syndrome, the primary type is more common than was originally suspected, and that both antinuclear antibody and nail-fold capillary microscopy, but not photoelectric plethysmography, can distinguish patients with primary Raynaud syndrome from those with either a connective tissue disease or a probable connective tissue disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783344     DOI: 10.1016/s0022-3476(89)80604-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

1.  The effects of stress, anxiety, and outdoor temperature on the frequency and severity of Raynaud's attacks: the Raynaud's Treatment Study.

Authors:  K M Brown; S J Middaugh; J A Haythornthwaite; L Bielory
Journal:  J Behav Med       Date:  2001-04

2.  Nailfold capillary microscopy in healthy children and in childhood rheumatic diseases: a prospective single blind observational study.

Authors:  P Dolezalova; S P Young; P A Bacon; T R Southwood
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

Review 3.  Raynaud's phenomenon: its relevance to scleroderma.

Authors:  J J Belch
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 4.  Raynaud phenomenon in children.

Authors:  Ran D Goldman
Journal:  Can Fam Physician       Date:  2019-04       Impact factor: 3.275

5.  Noninvasive evaluation of cardiac autonomic modulation in children with primary Raynaud’s phenomenon: a controlled study.

Authors:  Mehmet Burhan Oflaz; İbrahim Ece; Ayşe Esin Kibar; Şevket Ballı; Demet Alaygut; Ahmet Sami Guven; Fatih Bolat; Fatma Duksal; Ömer Cevit
Journal:  Clin Rheumatol       Date:  2014-01       Impact factor: 2.980

Review 6.  Recognition and management of scleroderma in children.

Authors:  I Foeldvari; N Wulffraat
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 7.  Systemic and localized scleroderma in children: current and future treatment options.

Authors:  Margalit E Rosenkranz; Lucila M A Agle; Petros Efthimiou; Thomas J A Lehman
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 8.  Pediatric scleroderma: systemic or localized forms.

Authors:  Kathryn S Torok
Journal:  Pediatr Clin North Am       Date:  2012-04-06       Impact factor: 3.278

9.  Juvenile onset systemic sclerosis: a single center experience of 23 cases from Asia.

Authors:  Ramnath Misra; Gurmeet Singh; Parshant Aggarwal; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2006-12-19       Impact factor: 3.650

10.  Primary Raynaud's phenomenon in an infant: a case report and review of literature.

Authors:  Anjali A Sharathkumar; Paul Castillo-Caro
Journal:  Pediatr Rheumatol Online J       Date:  2011-07-18       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.